top of page
The Professional Network for Healthcare Experts
Mankind Pharma agrees €48 million acquisition of 70% stake in Armed Cell Therapeutics to enter CAR-T oncology
Mankind Pharma has agreed to acquire a 70% stake in Belgium's Armed Cell Therapeutics for €48 million, marking its entry into next-generation CAR-T oncology therapies.
nuaxia
3 days ago2 min read
Biocon and Genentech reach global Pebrilzo biosimilar patent settlement establishing launch dates
Biocon and Genentech have reached a global patent settlement and licence agreement establishing planned launch windows for Pebrilzo, Biocon's pertuzumab biosimilar to Perjeta.
nuaxia
4 days ago2 min read
Eton licenses Aquestive's Libervant seizure rescue film for exclusive US commercialisation
Eton Pharmaceuticals has secured exclusive US commercialisation rights to Aquestive Therapeutics' Libervant diazepam buccal film for the investigational treatment of seizure clusters.
nuaxia
4 days ago2 min read
Gilead signs Vir Biotechnology oncology collaboration worth up to $1.9 billion for masked T-cell engagers
Gilead has entered a global oncology collaboration with Vir Biotechnology worth potentially $1.9 billion to develop masked T-cell engagers for solid tumours.
nuaxia
4 days ago2 min read
Galderma agrees $1.5 billion acquisition of ZO Skin Health to expand dermatological skincare portfolio
Galderma has agreed to acquire ZO Skin Health for an enterprise value of $1.5 billion, expanding its physician-dispensed dermatological skincare portfolio.
nuaxia
4 days ago2 min read
bottom of page